Literature DB >> 28005154

[Pathogenesis of urological complications after radiation therapy].

Y Tolkach1, G Kristiansen2.   

Abstract

Radiation therapy is a treatment modality that is often used in the uro-oncological setting. The common indication for the radiation therapy in the urological sphere is prostate cancer, whether it is used primarily as a radical approach, or postoperatively as adjuvant or salvage therapy. All urological organs are sensitive to radiation injury with the urinary bladder being the most susceptible with a typical cascade including acute and late changes, arising in the dose-dependent manner. The common indication for radiation therapy in urology is prostate cancer, which collaterally affects the urinary bladder and rarely urethra (especially the bulbo-membranous urethra). Ureteral damage and stricture formation is almost always restricted to the cases of intraoperative therapy and external beam radiation therapy for other urological malignancies (gynecological organs, rectum, retroperitoneal soft tissue tumors) and should not be underestimated. Postradiotherapeutic tissue changes, especially of the prostate, can cause difficulties for pathologists and urologists with regard to diagnosis of prostate cancer recurrence and salvage therapy.

Entities:  

Keywords:  Cell cycle; Prostate; Radiation dosage; Radiation therapy; Urinary bladder

Mesh:

Year:  2017        PMID: 28005154     DOI: 10.1007/s00120-016-0292-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  30 in total

1.  Risk factors for the development of prostate brachytherapy related urethral strictures.

Authors:  Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Richard L Anderson; Zachariah A Allen; Edward Adamovich
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

2.  Routine immunohistochemical staining for high-molecular weight cytokeratin 34-beta and alpha-methylacyl CoA racemase (P504S) in postirradiation prostate biopsies.

Authors:  Mildred B Martens; Jeremy H Keller
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

Review 3.  Management of radiation cystitis.

Authors:  Shaun G Smit; Chris F Heyns
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

Review 4.  Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.

Authors:  Hiromichi Ishiyama; Takahiro Hirayama; Pavan Jhaveri; Takefumi Satoh; Arnold C Paulino; Bo Xu; Edward Brian Butler; Bin S Teh
Journal:  Am J Clin Oncol       Date:  2014-06       Impact factor: 2.339

5.  Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.

Authors:  Sean P Elliott; Maxwell V Meng; Eric P Elkin; Jack W McAninch; Janeen Duchane; Peter R Carroll
Journal:  J Urol       Date:  2007-06-13       Impact factor: 7.450

Review 6.  Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches.

Authors:  Deliu Victor Matei; Matteo Ferro; Barbara Alicja Jereczek-Fossa; Giuseppe Renne; Nicolae Crisan; Danilo Bottero; Claudia Mazzarella; Daniela Terracciano; Riccardo Autorino; Ottavio De Cobelli
Journal:  Urol Int       Date:  2015-03-04       Impact factor: 2.089

7.  Radiation or chemotherapy cystitis with "pseudocarcinomatous" features.

Authors:  Theresa Y Chan; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

Review 8.  Fundamentals on the pathology of prostatic carcinoma after brachytherapy.

Authors:  Burkhard Helpap
Journal:  World J Urol       Date:  2002-08-15       Impact factor: 4.226

Review 9.  Normal tissue tolerance to intraoperative radiotherapy.

Authors:  William F Sindelar; Timothy J Kinsella
Journal:  Surg Oncol Clin N Am       Date:  2003-10       Impact factor: 3.495

Review 10.  A Narrative Review on the Pathophysiology and Management for Radiation Cystitis.

Authors:  C Browne; N F Davis; E Mac Craith; G M Lennon; D W Mulvin; D M Quinlan; Gerard P Mc Vey; D J Galvin
Journal:  Adv Urol       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.